Sanofi US Services Inc.

FDA Regulatory Profile

Sanofi US Services Inc. has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record.

Latest inspection
Feb 7, 2019 · NAI

Newer recall under related name Chattem: Mar 26, 2025, D-0362-2025.

Reviewing Sanofi US Services Inc. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Request a free FDA snapshot

Or get Sanofi US Services Inc.'s full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site, in Claude, Cursor or ChatGPT.

Get a free API key

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Oct 23, 2026Not statedCurrent
510(k) clearances0Oct 4, 2026Not statedCurrent
Inspections1Oct 26, 2026Not statedCurrent
Compliance actions0Oct 23, 2026Not statedCurrent

Related names

NameRecalls510(k)InspectionsComplianceMost recent recall
Chattem
Same company group
21271Mar 26, 2025 (D-0362-2025)
Sanofi Genzyme
Same company group
1000Dec 11, 2017 (Z-0607-2018)
Genzyme Corporation
Same company group
66261Oct 12, 2017 (D-0075-2018)
Sanofi Winthrop Industrie
Same company group
00571—
Sanofi
Same company group
02120—
Chattem Chemicals
Same company group
0060—
Sanofi Aventis Singapore Pte
Same company group
0060—
Genzyme Biosurgery
Same company group
0400—
Genzyme Polyclonals
Same company group
0020—
Sanofi Aventis Recherche And Developpement
Same company group
0010—
Sanofi Chimie
Same company group
0010—

Recent FDA Inspections

DateSiteProductClassificationFEI
Feb 7, 2019Morristown, NJDevicesNo Action Indicated (NAI)3010770778

NAI means no objectionable conditions or practices were found during the inspection. VAI means objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action. OAI means regulatory and/or administrative actions are recommended.